These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9057255)

  • 1. Comparison of two pseudorabies virus vaccines, that differ in capacity to reduce virus excretion after a challenge infection, in their capacity of reducing transmission of pseudorabies virus.
    Bouma A; De Jong MC; Kimman TG
    Vet Microbiol; 1997 Feb; 54(2):113-22. PubMed ID: 9057255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission of two pseudorabies virus strains that differ in virulence and virus excretion in groups of vaccinated pigs.
    Bouma A; De Jong MC; Kimman TG
    Am J Vet Res; 1996 Jan; 57(1):43-7. PubMed ID: 8720236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of maternal immunity on the transmission of pseudorabies virus and on the effectiveness of vaccination.
    Bouma A; De Jong MC; Kimman TG
    Vaccine; 1997 Feb; 15(3):287-94. PubMed ID: 9139488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental quantification of transmission of genetically engineered pseudorabies virus.
    Mulder WA; De Jong MC; Priem J; Bouma A; Pol JM; Kimman TG
    Vaccine; 1995 Dec; 13(18):1763-9. PubMed ID: 8701591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inactivated gE-deleted pseudorabies vaccine provides complete clinical protection and reduces virus shedding against challenge by a Chinese pseudorabies variant.
    Wang J; Guo R; Qiao Y; Xu M; Wang Z; Liu Y; Gu Y; Liu C; Hou J
    BMC Vet Res; 2016 Dec; 12(1):277. PubMed ID: 27923365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine.
    Mettenleiter TC; Klupp BG; Weiland F; Visser N
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1723-33. PubMed ID: 8021601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs.
    Arellano PE; Morrison RB; Molitor TW; Thawley DG
    J Am Vet Med Assoc; 1992 Mar; 200(5):685-91. PubMed ID: 1314793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the ability of a TK-negative and gI/gE-negative pseudorabies virus (PRV) mutant inoculated by different routes to protect pigs against PRV infection.
    Ferrari M; Brack A; Romanelli MG; Mettenleiter TC; Corradi A; Dal Mas N; Losio MN; Silini R; Pinoni C; Pratelli A
    J Vet Med B Infect Dis Vet Public Health; 2000 Dec; 47(10):753-62. PubMed ID: 11204130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs.
    Mengeling WL; Brockmeier SL; Lager KM
    Arch Virol; 1994; 134(3-4):259-69. PubMed ID: 8129615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses.
    Brockmeier SL; Lager KM; Tartaglia J; Riviere M; Paoletti E; Mengeling WL
    Vet Microbiol; 1993 Dec; 38(1-2):41-58. PubMed ID: 8128602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs.
    Gerdts V; Jöns A; Mettenleiter TC
    Vet Microbiol; 1999 Mar; 66(1):1-13. PubMed ID: 10223318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge.
    Vilnis A; Sussman MD; Thacker BJ; Senn M; Maes RK
    Vet Microbiol; 1998 May; 62(2):81-96. PubMed ID: 9695282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth properties and vaccine efficacy of recombinant pseudorabies virus defective in glycoprotein E and thymidine kinase genes.
    Wu CY; Liao CM; Chi JN; Chien MS; Huang C
    J Biotechnol; 2016 Jul; 229():58-64. PubMed ID: 27164258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs.
    Wang Y; Yuan J; Cong X; Qin HY; Wang CH; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
    Clin Vaccine Immunol; 2015 Oct; 22(10):1121-9. PubMed ID: 26311244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bartha-k61 vaccine protects growing pigs against challenge with an emerging variant pseudorabies virus.
    Zhou J; Li S; Wang X; Zou M; Gao S
    Vaccine; 2017 Feb; 35(8):1161-1166. PubMed ID: 28131396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serological tests for the detection of pseudorabies gE antibodies during early infection.
    Kinker DR; Swenson SL; Wu LL; Zimmerman JJ
    Vet Microbiol; 1997 Apr; 55(1-4):99-106. PubMed ID: 9220601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against pseudorabies virus infection by intranasal vaccination of newborn pigs.
    McCaw MB; Xu J
    Am J Vet Res; 1993 Apr; 54(4):527-33. PubMed ID: 8387249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gD&gC-substituted pseudorabies virus vaccine strain provides complete clinical protection and is helpful to prevent virus shedding against challenge by a Chinese pseudorabies variant.
    Zhang C; Liu Y; Chen S; Qiao Y; Guo M; Zheng Y; Xu M; Wang Z; Hou J; Wang J
    BMC Vet Res; 2019 Jan; 15(1):2. PubMed ID: 30606159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the effectiveness of Pseudorabies marker vaccines in experiments and field trials.
    Bouma A
    Biologicals; 2005 Dec; 33(4):241-5. PubMed ID: 16275010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with recombinant vaccinia virus vaccines expressing glycoprotein genes of pseudorabies virus in the presence of maternal immunity.
    Brockmeier SL; Lager KM; Mengeling WL
    Vet Microbiol; 1997 Nov; 58(2-4):93-103. PubMed ID: 9453121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.